Paradoxical Increase in CirculatingAspergillusAntigen during Treatment with Caspofungin in a Patient with Pulmonary Aspergillosis

This publication has 16 references indexed in Scilit:

• Efficacy of amphotericin B or amphotericin B–intralipid in combination with caspofungin against experimental aspergillosis
  Journal of Infection, 2006
• Comparison of Galactomannan Detection, PCR-Enzyme-Linked Immunosorbent Assay, and Real-Time PCR for Diagnosis of Invasive Aspergillosis in a Neutropenic Rat Model and Effect of Caspofungin Acetate
  Clinical and Vaccine Immunology, 2005
• Bifidobacterial Lipoglycan as a New Cause for False-Positive Platelia Aspergillus Enzyme-Linked Immunosorbent Assay Reactivity
  Journal of Clinical Microbiology, 2005
• Evaluation of Serum Sandwich Enzyme-Linked Immunosorbent Assay for Circulating Galactomannan during Caspofungin Therapy: Results from the Caspofungin Invasive Aspergillosis Study
  Clinical Infectious Diseases, 2005
• False‐Positive Galactomannan PlateliaAspergillusTest Results for Patients Receiving Piperacillin‐Tazobactam
  Clinical Infectious Diseases, 2004
• The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agent
  British Journal of Clinical Pharmacology, 2003
• Single- and Multiple-Dose Pharmacokinetics of Caspofungin in Healthy Men
  Antimicrobial Agents and Chemotherapy, 2002
• Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia
  Antimicrobial Agents and Chemotherapy, 2002
• Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation
  Blood, 2001
• In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium Isolates
  Antimicrobial Agents and Chemotherapy, 2001